SOURCE: DSM N.V.

September 07, 2007 03:21 ET

DSM - Repurchase and cancellation of shares (week 36)

HEERLEN, NETHERLANDS--(Marketwire - September 7, 2007) -


Royal DSM N.V. has repurchased 519,921 of its own shares in the period from 30 August 2007 up to and including 5 September 2007 at an average price of EUR 37.37. This is in accordance with the second phase of the share buyback program, announced on 27 April 2007. The consideration of this repurchase was EUR 19.4 million.

The total number of shares repurchased under the second phase of this program to date is 13,516,758 shares for a total consideration of EUR 496.4 million.

In accordance with the cancellation process initiated on 2 July 2007, Royal DSM N.V. announces that 6,700,000 shares, bought during the second phase of the share buyback program, have been cancelled as per 3 September 2007. As a result the number of issued ordinary shares has decreased by 3.4% to 188,553,008.

DSM

DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company develops, produces and sells innovative products and services that help improve the quality of life. DSM's products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 - Building on Strengths, focuses on accelerating profitable and innovative growth of the company's specialties portfolio. The key drivers of this strategy are market-driven growth and innovation plus an increased presence in emerging economies. The group has annual sales of over EUR 8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa, Australia and the Americas. More information about DSM can be found at www.dsm.com.


For more information:

DSM Corporate Communications     DSM Investor Relations
Elvira Luykx                     Dries Ausems
tel. +31 (0) 45 5782035          tel. +31 (0) 45 5782864
fax  +31 (0) 45 5740680          fax  +31 (0) 45 5782595
e-mail media.relations@dsm.com   e-mail investor.relations@dsm.com

Press release-pdf: http://hugin.info/130663/R/1152028/221236.pdf


Copyright © Hugin ASA 2007. All rights reserved.

Contact Information